| Message: | 1.PharmaLegacy Laboratories (Shanghai) Co., Ltdis a company with High quality Respiratory Disease Model,Osteoarthritis ModelandRheumatoid arthritis Model as the main business. We are committed to providing quality service of PDX Model. PharmaLegacy Laboratories (Shanghai) Co., Ltdwas established in 10 years ago, As a company with a high sense of social responsibility, PharmaLegacyhas established a high reputation for superior quality and expertise in Humanized mouse modelfield
2.PharmaLegacy Laboratories (Shanghai) Co., Ltdis committed to the continuous improvement of theRespiratory Disease Modelservice, become a society, customers, shareholders and employees long-term trust of the company. Our Company adhering to pirit of for the sake of customers, and win-win with customers , and through PharmaLegacy staff continuous innovation and development to provide first-class Most popular Respiratory Disease Model,Liver Fibrosis Model the four major advantages,AutoimmuneDiseasesModel looking for a company,AutoimmuneDiseasesModel the difference for enterprises , is what we have been working for. Details:Carbon tetrachloride (CCl4)-induced hepatic fibrosis and cirrhosis in rodents is a well-established and widely accepted experimental model for the study of liver fibrosis and cirrhosis. In many aspects it mirrors the pattern of human disease associated with toxic damage. For example, the α-SMA expression, Stellate cell activation and key matrix components including collagen-1, MMPs and their inhibitors TIMPs have been indicated in the pathogenesis of this model. CCl4 induction elicits a reproducible and predictable fibrotic response in liver, making it a valuable basis for preclinical pharmacology studies of anti-fibrotic and anti-cirrhotic therapeutics and the pathophysiology study of liver fibrosis-cirrhosis-HCC changes
3.With the rapid development of business simultaneously, PharmaLegacy always keeps the balance between external opportunities and internal management |
my account
